# [Published on 2024-03-09](index.md)

* [2024-03-09, 17:19:44](https://news.ycombinator.com/item?id=39653125) - [FDA Designates MM120 (LSD) Breakthrough Therapy for Generalized Anxiety Disorder](https://www.businesswire.com/news/home/20240307733599/en/MindMed-Receives-FDA-Breakthrough-Therapy-Designation-and-Announces-Positive-12-Week-Durability-Data-From-Phase-2B-Study-of-MM120-for-Generalized-Anxiety-Disorder)
